Skip to main content
CDC Website

English

I Have TB What Now? Video

The "I Have TB What Now?" video provides information on the steps involved after an individual is diagnosed with active TB or latent TB infection. The video is available in English, Mandarin, and Spanish.

Latent TB Treatment (3HP) Trifold

A trifold to help individuals stay on track with the 12-dose (3HP) treatment regimen for latent TB infection. The trifold includes a medication tracker and space to write a reminder for the next clinic visit.

TB Contact Investigation Tools and Case Studies

The goal of this presentation is to help secure complete and successful contact investigations. The 50-minute webinar provides an overview of contact investigations, as well as information on available resources. Participants will also hear case studies from field staff that manage contact investigations.

Tuberculosis Targeted Testing webinar

This 60-minute webinar shares information on the basic concepts and best practices for TB targeted testing. Presenters illustrate the history and future of targeted testing in Texas. Information on the Texas 1115 Medicaid Waiver TB Project – TB Infection Targeted Testing is also presented in this webinar.

Nursing Guide for Managing Side Effects to Drug-resistant TB Treatment

The guide, based on nursing and drug-resistant TB literature, establishes best practice nursing assessment and intervention guidance. The content was created to act as a reference and job aid for nurses to:
1.Identify symptoms that may indicate a side effect related to DR-TB treatment or antiretroviral medication;
2.Assess for severity as well as other potential contributors; and
3.Intervene appropriately in order to minimize patient discomfort, reduce side effect progression, and ultimately support successful treatment completion.

Tuberculosis and HIV

This resource emphasizes the severity of TB and HIV coinfection. The fact sheet includes information on how many people died in 2022 from AIDS-related TB, an estimated number of averted deaths between 2010 and 2022 due to TB treatment and antiretroviral therapy, and more.